Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial. [PDF]
Park Y, Kim H, Kim S, Cho KJ.
europepmc +1 more source
"Created: 3/16/2020..."--Document properties ...
Ohio Occupational Therapy, Physical Therapy, and Athletic Trainers Board
core
[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich +19 more
wiley +1 more source
Sarah Farrant,1 Giuseppe Giannaccare,2 Chris Hong Long Lim,3– 5 Giulia Coco6 1Earlam and Christopher Optometrists Ltd, Taunton, UK; 2Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, Italy; 3Department of Ophthalmology ...
Farrant S +3 more
doaj
Home-based low-level light therapy using a commercial LED mask for dry eye disease. [PDF]
Scuderi L +3 more
europepmc +1 more source
Metabolomic study combined with the low-level light therapy of Chinese acupuncture points and combined oral contraceptives in treatment of primary dysmenorrhea: A prospective, multicenter, randomized controlled study. [PDF]
Wang H +7 more
europepmc +1 more source
ABSTRACT Objective To assess the association and discriminative performance of serum biomarkers with clinical disease progression and survival in patients with amyotrophic lateral sclerosis (ALS). Methods This retrospective study, conducted at Houston Methodist Hospital, Houston, TX, used longitudinal serum samples collected between January 2018 and ...
David R. Beers +7 more
wiley +1 more source
Treatment-Resistant Fibrosing Alopecia in a Pattern Distribution Showing Clinical Improvement With Home Low-Level Light Therapy. [PDF]
Maas D +4 more
europepmc +1 more source
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak +4 more
wiley +1 more source
Low-Level Light Therapy in Postherpetic Neuralgia: A Review of Mechanistic Insights and Clinical Implications. [PDF]
Ma YC, Chiang YC, Yu S.
europepmc +1 more source

